Imaging Bio Regulatory News (IBAI)

Imaging Biometrics Limited

("IBAI" or the "Company")

Board Changes

The Company announces that Dr Al Musella will step down from the Board of Directors with effect from 31 December 2025.

Although Dr Musella will no longer serve on the IBAI Board, he will remain closely involved with IBAI's wholly owned subsidiary, Imaging Biometrics LLC in a more direct and frequent capacity. Dr Musella will assume the role of Medical Advisor, providing clinical insight and strategic input to product development and marketing efforts.

The Board looks forward to continuing its collaboration with Dr Musella in this enhanced advisory role and thanks him for his ongoing commitment to the business.

--ENDS-

The Directors of the Company accept responsibility for the contents of this announcement.

For further information, please contact:

About Imaging Biometrics® LLC:  IB is a wholly owned subsidiary of Imaging Biometrics Limited, (LON: IBAI), and focuses on delivering quantitative imaging platforms and therapeutics that transform how clinicians diagnose and treat patients more efficiently and effectively. For more information about Imaging Biometrics, visit the company's website at www.imagingbiometrics.com. Follow IB on X, @ImgBiometrics.